A detailed history of Ifrah Financial Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ifrah Financial Services, Inc. holds 6,482 shares of BMY stock, worth $381,595. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,482
Previous 6,246 3.78%
Holding current value
$381,595
Previous $259,000 29.34%
% of portfolio
0.09%
Previous 0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $9,359 - $12,213
236 Added 3.78%
6,482 $335,000
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $11,229 - $14,784
-279 Reduced 4.28%
6,246 $259,000
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $214,374 - $243,059
-4,468 Reduced 40.64%
6,525 $353,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $23,124 - $27,594
-477 Reduced 4.16%
10,993 $564,000
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $1,678 - $1,877
-29 Reduced 0.25%
11,470 $665,000
Q2 2023

Aug 01, 2023

SELL
$63.71 - $70.74 $7,199 - $7,993
-113 Reduced 0.97%
11,499 $735,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $48,231 - $54,705
-734 Reduced 5.95%
11,612 $804,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $19,927 - $23,597
-291 Reduced 2.3%
12,346 $888,000
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $15 - $8,990
-117 Reduced 0.92%
12,637 $898,000
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $16,049 - $17,675
-221 Reduced 1.7%
12,754 $982,000
Q1 2022

May 03, 2022

BUY
$61.48 - $73.72 $115,705 - $138,741
1,882 Added 16.97%
12,975 $948,000
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $589 - $687
11 Added 0.1%
11,093 $692,000
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $2,958 - $3,465
50 Added 0.45%
11,082 $656,000
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $18,015 - $19,619
-291 Reduced 2.57%
11,032 $737,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $177,723 - $199,886
2,995 Added 35.96%
11,323 $715,000
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $8,025 - $9,094
-139 Reduced 1.64%
8,328 $517,000
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $8,327 - $9,227
-145 Reduced 1.68%
8,467 $510,000
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $19,241 - $22,495
-351 Reduced 3.92%
8,612 $506,000
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $881 - $1,281
19 Added 0.21%
8,963 $500,000
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $440,134 - $574,115
8,944 New
8,944 $574,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ifrah Financial Services, Inc. Portfolio

Follow Ifrah Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ifrah Financial Services, Inc. with notifications on news.